Research Papers Published
- "Indicator based assessment of medicine storage and inventory management practices in various public sector hospitals of district Srinagar" Indian Journal of Pharmacy Practice, 8(4): 1 -4 {ISSN: 0974-8326} Impact Factor= 0
- "Off-label use of medicines in children" International Journal of Pharmaceutical Sciences and Research, 7(5): 1820 -28 {ISSN: 0975-8232} Impact Factor= 1.54
- "Indicator based assessment of medicines procurement practices in various public sector hospitals of district Srinagar" International Archives in Biomedical and Clinical Research, 2(2): 11 -18 {ISSN: 2494-9894} Impact Factor= 2.86
- "Development of an indicator-based tool for the assessment of medicines selection practices in various public sector hospitals" International Journal of Pharmacy and Pharmaceutical Sciences, 8(11): 205 -08 {ISSN: 0975-1491} Impact Factor= 0.282
- "Frequency, types, severity, preventability and costs of Adverse Drug Reactions at a tertiary care hospital" Journal of Pharmacological and Toxicological Methods, 81(7): 323 -34 {ISSN: 1056-8719} Impact Factor= 2.37
- "Medicines management in hospitals: A supply chain perspective." Systematic Reviews in Pharmacy (Phcog.Net), 8(1): 80 -85 {ISSN: 0975-8453} Impact Factor= 0.14
- "Knowledge, attitude and perception of healthcare providers at internal medicine ward of a tertiary care hospital towards pharmaceutical care" International Journal of Pharmaceutical Sciences and Research (Society of Pharmaceutical Sciences and Research), 8(2): 831 -837 {ISSN: 2320-5148} Impact Factor= 1.11
- "Upsurge of renewed interest in the use of HRT among post-menopausal women in the light of revised global consensus statement" Physicians Academy, 11(3): 19 -24 {ISSN: 0973-998X} Impact Factor= 0
- "Time to evolve Universal Health Coverage policy framework for the state of Jammu and Kashmir" Physicians Academy, 11(10): 101 -105 {ISSN: 0973-998X} Impact Factor= 0
- "Evaluation of Medicines Forecasting and Quantification Practices in Various Public Sector Hospitals Using Indicator Based Assessment Tool" Journal of Applied Pharmaceutical Science, 7(12): 72 -76 {ISSN: 2231-3354} Impact Factor= 0.649
- "Averting Antibiotic Apocalypse in J&K state." Physicians Academy, 11(12): 124 -125 {ISSN: 0973-998X} Impact Factor= 0
- "Recent promising advances in the development of antimicrobial agents - a review." Journ Drug Deliv Therap 2018; 8(5): 82-86., 8(5): 82 -86 {ISSN: 2250-1177} Impact Factor= 0
- "New antimicrobial agents - a review." Intern Journ Pharm Biol Sc 2018; 8(3): 352-59., 8(3): 352 -359 {ISSN: 2321-3272} Impact Factor= 0
- "Role of adipokines and free fatty acids in insulin resistance - a review." Intern Journ Adv Res Sc Eng 2018;07(04): 2115-23., 7(4): 2115 -2123 {ISSN: 2319-8346} Impact Factor= 2.83
- "Polycystic ovarian Syndrome - a multifaceted disease" Intern Journ Pharm Sc & Res, 10(3): 1072 -1079 Impact Factor=
- "Drug safety and Pharmacovigilance: An overview" Journal of Drug Delivery & Therapeutics, 9(2): 543 -548 Impact Factor=
- "Comparative Evaluation of Biomarkers of In?ammation Among Indian Women With Polycystic Ovary Syndrome (PCOS) Consuming Vegetarian vs. Non-vegetarian Diet" Frontiers in Endocrinology, 10(11): 699 -705 Impact Factor=
- "Drug safety and Pharmacovigilance: An overview" Journal of Drug Delivery & Therapeutics, 9(2): 543 -548 Impact Factor=
- "Connecting Pharmacists and Other Health Care Providers (HCPs) towards Drug Therapy Optimization: A Pharmaceutical Care Approach." International Journal of Clinical Practice, 2023(1): 1 -7 {ISSN: ISSN: 1368} Impact Factor= 2.6
- "Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance." Drug Safety, 46(1): 517 -532 {ISSN: 1179-1942} Impact Factor= 4.3
- "Pre-polycystic ovary syndrome and polymenorrhoea as a new facet of polycystic ovary syndrome (PCOS): Evidence from a single centre dataset." Clinical Endocrinology, 99(4): 566 -578 {ISSN: 1365-2265} Impact Factor= 3.2
Books Published
- "Stakeholders in pharmaceutical policy development in the book entitled “Stakeholders in pharmaceutical policy development” for the book “Pharmacovigilance and Regulations”". Intechopen International. {ISBN: 978-1-80356-127-1} pp 14
- "Inter-relationship between polycystic ovary syndrome and metabolic syndrome". Elsevier - Academic Press. {ISBN: 978-0-323-85732-1} pp 27
Research Projects Details:
Title of the Project | Funding Agency | Dated | Amount (in Rs.) |
---|
Baseline evaluation of access to medicines in the state of Jammu and Kashmir | Public Health Foundation of India, New Delhi | 30-06-2014 | 588,000.00 |